Enhancement of Anti-Inflammatory and Osteogenic Abilities of Mesenchymal Stem Cells via Cell-to-Cell Adhesion to Periodontal Ligament-Derived Fibroblasts
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2017, 1-12
Abstract
Mesenchymal stem cells (MSCs) are involved in anti-inflammatory events and tissue repair; these functions are activated by their migration or homing to inflammatory tissues in response to various chemokines. However, the mechanism by which MSCs interact with other cell types in inflammatory tissue remains unclear. We investigated the role of periodontal ligament fibroblasts (PDL-Fs) in regulating the anti-inflammatory and osteogenic abilities of bone marrow-derived- (BM-) MSCs. The expression of monocyte chemotactic protein- (MCP-)1 was significantly enhanced by stimulation of PDL-Fs with inflammatory cytokines. MCP-1 induced the migratory ability of BM-MSCs but not PDL-Fs. Expression levels of anti-inflammatory and inflammatory cytokines were increased and decreased, respectively, by direct-contact coculture between MSCs and PDL-Fs. In addition, the direct-contact coculture enhanced the expression of MSC markers that play important roles in the self-renewal and maintenance of multipotency of MSCs, which in turn induced the osteogenic ability of the cells. These results suggest that MCP-1 induces the migration and homing of BM-MSCs into the PDL inflammatory tissue. The subsequent adherence of MSCs to PDL-Fs plays an immunomodulatory role to terminate inflammation during wound healing and upregulates the expression stem cell markers to enhance the stemness of MSCs, thereby facilitating bone formation in damaged PDL tissue.Keywords
Funding Information
- JSPS KAKENHI (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- JSPS KAKENHI (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- JSPS KAKENHI (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- JSPS KAKENHI (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- JSPS KAKENHI (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- JSPS KAKENHI (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- Ministry of Education, Culture, Sports, Science and Technology (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
- Keiryokai Research Foundation (JP25463053, JP16K11654, JP25893221, JP15K20633, JP26670852, JP16H05534, 120)
This publication has 79 references indexed in Scilit:
- Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell ApoptosisCell Stem Cell, 2012
- Mesenchymal Stem Cells Secrete Multiple Cytokines That Promote Angiogenesis and Have Contrasting Effects on Chemotaxis and ApoptosisPLOS ONE, 2012
- How mesenchymal stem cells interact with tissue immune responsesTrends in Immunology, 2012
- Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and NeuroprotectionPLOS ONE, 2011
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative MedicineJournal of Dental Research, 2009
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and PlasticityStem Cells, 2005
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998